Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My apologies, scanner pulled the wrong one,
CIG valuation is about 275M USD, the 6K is in Brazilian dollars
https://finance.yahoo.com/sec-filing/CIG/0001292814-24-000052_1157557/
Sorry this is a crappy link im on mobile currently,
read all the (6K)filings, very informative
IMO
Their 6 K filing. Jan 10 2024 show 1.35B,
If you read the few posts ( i made) about SPZI a few weeks ago you will see i was negative for a specific reason, the charts were positive snd ive been day trading an average of twice a week.
Charts are a strong tool in any market.
Anyone gaving delays getting orders posted in L2, looks like broker splitting my orders
I sold my Spooz when i saw yesterday's sec gilings with goulding brother as lawyer.
Follow RSHN history
?
dehaze
search
RushNet, Inc. (OTC Pink: RSHN), Announces Appointment of CEO, Chairman of the Board and Chief Medical Officer
July 20, 2018 10:00 ET| Source: RushNet, Inc.Follow
Richard Goulding MD, a Florida based physician endeavoring to develop innovative and quality HEMP based products with enhanced efficacy, cultivated an impressive management team for growth and will serve as Chairman of the Board of Directors
Palm Coast, FL., July 20, 2018 (GLOBE NEWSWIRE) -- RushNet, Inc. . (OTC Pink: RSHN) announces that Richard Goulding, MD, appointed Frank Deangelo as the Chief Executive Officer of RushNet, Inc. Mr. Deangelo is the retired President and CEO of Applejam, Inc. which was one of the world’s largest restaurant franchises which he grew to having over $120,000,000 in sales with over 2500 employees before selling it.
Dr. Goulding will continue to also serve in his roles as Chairman of the Board of Directors and Chief Medical Officer. Dr. Goulding is quoted as saying “As we continue to cultivate strategic relationships that will inure to the benefit of multiple parties.” Dr. Goulding is further quoted as saying “our mission is to enhance the value of RushNet and other companies with whom it conducts its business, for the benefit of the shareholders, as we foster beneficial financial transactions.
Many investors have contacted the Company inquiring about the prospects of a reverse split. We would like to inform them that we do not think a reverse split is necessary or even helpful
Actually just was checking out SPOOZ, bought 500K then saw the SEC filings with Gouldings brother as lawyer.
Promply, Sold yesterday slight profit
GLTU
Here is a trail you can dd if your serious.
Richard goulding and the lawyer are brothers.
BTW if HuggyB sayz he dosent remember pull up the old blogs and ask why.
Luck 2 you
?
dehaze
search
RushNet, Inc. (OTC Pink: RSHN), Announces Appointment of CEO, Chairman of the Board and Chief Medical Officer
July 20, 2018 10:00 ET| Source: RushNet, Inc.Follow
Richard Goulding MD, a Florida based physician endeavoring to develop innovative and quality HEMP based products with enhanced efficacy, cultivated an impressive management team for growth and will serve as Chairman of the Board of Directors
Palm Coast, FL., July 20, 2018 (GLOBE NEWSWIRE) -- RushNet, Inc. . (OTC Pink: RSHN) announces that Richard Goulding, MD, appointed Frank Deangelo as the Chief Executive Officer of RushNet, Inc. Mr. Deangelo is the retired President and CEO of Applejam, Inc. which was one of the world’s largest restaurant franchises which he grew to having over $120,000,000 in sales with over 2500 employees before selling it.
Dr. Goulding will continue to also serve in his roles as Chairman of the Board of Directors and Chief Medical Officer. Dr. Goulding is quoted as saying “As we continue to cultivate strategic relationships that will inure to the benefit of multiple parties.” Dr. Goulding is further quoted as saying “our mission is to enhance the value of RushNet and other companies with whom it conducts its business, for the benefit of the shareholders, as we foster beneficial financial transactions.
Many investors have contacted the Company inquiring about the prospects of a reverse split. We would like to inform them that we do not think a reverse split is necessary or even helpful
Isnt their lawyer associated with goulding and rushnet history
Possibly they were all interconnected at one time. GRPS did spin off.
So isnt the lawyer goulding associated with the CEO of RUSHNET from a ciuple years ago?
Isnt the lawyer Goulding associated with RUSHNET from a couple years ago?
Welcome
New MULN 8K, filed.
Item 8.01. Other Events.
In April 2023, British Airways (“BA”) began piloting Mullen’s Campus EV cargo van at Los Angeles International Airport (“LAX”). Subsequently and after the success of the pilot, both LAX and Chicago O’Hare International Airport (“ORD”) locations have purchased Campus EV cargo vans in support of BA airport ground operations. The transactions for both the LAX and ORD closed with the receipt by Mullen of payment from British Airways on August 31, 2023.
Look for ripple effects at all major air ports.
The same people buying it post market.
M2, not going to happen. Good luck.
Well I'm trying to get another 20K at this level, I need to get near current PPS.
90 to 100k bag full.
I'm thinking we are going to OTC for a while.
A 25/1 RS won't help at these levels.
A 100/1 would need to be voted on.
IMO,
OTC for 12 to 18 months then return to NASDAQ.
Thoughts anyone.
No RS needed, they can issue 350 to 400M securities anytime. The SEC filings are clear on this.
Nothing new, just vote your shares, like last time.
No lawsuits, repeat of previous info.
Inline Viewer
Select Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):January 13, 2023
MULLEN AUTOMOTIVE INC.
_____________________________________________________________
(Exact name of registrant as specified in its charter)
Delaware001-3488786-3289406(State or other jurisdiction of
incorporation)(Commission File Number)(IRS Employer Identification No.)
1405 Pioneer Street, Brea, California 92821
(Address, including zip code, of principal executive offices)
Registrant’s telephone number, including area code(714) 613-1900
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registeredCommon Stock, par value $0.001MULNThe Nasdaq Stock Market, LLC (Nasdaq Capital Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 8.01Other Events
On November 25, 2022, Mullen Automotive Inc. (the “Company”) filed a definitive proxy statement with the Securities and Exchange Commission (the “Commission”) in connection with a Special Meeting of Stockholders (the “Special Meeting”), and on December 16, 2022 and January 13, 2023, the Company filed amendment no.1 and amendment no.2 to the definitive proxy statement with the Commission (together the “Proxy Statement”).
The Proxy Statement discloses that, as of the close of business on November 21, 2022 (the “Special Meeting Record Date”), there were 1,659,097,754 shares of Common Stock outstanding, 1,925 shares of Series A Preferred Stock outstanding, one share of Series AA Preferred Stock outstanding, zero shares of Series B Preferred Stock outstanding, and 1,211,757 shares of Series C Preferred Stock outstanding. The Company’s Series D Preferred Stock par value $0.001 per share (the “Series D Preferred Stock”) have no voting rights except in a liquidation event, issuance of equity security having a preference over the Series D Preferred Stock, amendment of the Company’s Certificate of Incorporation or bylaws that adversely affect the rights of the Series D Preferred Stock, corporate dissolution or bankruptcy, as set forth in Section 8 of the Certificate of Designation for Series D Preferred Stock, and therefore the Series D Preferred Stock was not counted in connection to the Special Meeting.
Of these shares outstanding on the Special Meeting Record Date, 1,159,803,273 shares of Common Stock, and one share of Series AA Preferred Stock (collectively, the “New Shares”) were issued by the Company following the enactment of an amendment to the Company’s Certificate of Incorporation (the “2022 Certificate Amendment”) on July 26, 2022. The 2022 Certificate Amendment was approved at the Company’s July 26, 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The 2022 Certificate Amendment increased the number of shares of Common Stock authorized for issuance from 500,000,000 to a total of 1,750,000,000 shares of Common Stock, and increased the number of shares of Preferred Stock authorized for issuance from 58,000,000 to a total of 500,000,000 shares of Preferred Stock, with a corresponding increase in our total authorized capital stock, which includes Common Stock and Preferred Stock, from 558,000,000 shares to 2,250,000,000 shares. The 2022 Certificate Amendment became effective when it was filed with the Office of the Secretary of State of the State of Delaware on July 26, 2022.
On December 7, 2022, a putative stockholder class action was filed in the Court of Chancery of the State of Delaware, styled as Robbins v. Michery, et al., C.A. No. 2022-1131-LWW (the “Robbins Action”). On December 13, 2022, a second putative stockholder class action was filed in the Court of Chancery of the State of Delaware, styled as Foley v. Michery, et al., C.A. No. 2022-1147-LWW (the “Foley Action” and, together with the Robbins Action, the “Stockholder Actions”). The plaintiffs in the Stockholder Actions filed complaints alleging, among other things, that the number of shares of Common Stock issued and outstanding as of the Annual Meeting Record Date (the “Annual Meeting Record Date”) was 477,510,822 and that, based on this eligible share total, a majority of shares of Common Stock, when considered separately as a class, did not vote in favor of the increase in authorized shares at the 2022 Annual Meeting.
The Company does not believe that the filing and effectiveness of the 2022 Certificate Amendment is either invalid or ineffective. However, to resolve any uncertainty, the Company is pursuing actions to ratify the 2022 Certificate Amendment through the filing of a validation proceeding with the Delaware Court of Chancery (the “Court of Chancery”) pursuant to Section 205 of the Delaware General Corporation Law (“Section 205”). Section 205 permits the Court of Chancery, in its discretion, to ratify and validate potentially defective acts. The Court of Chancery has scheduled a hearing to consider the Company’s Section 205 petition on January 23, 2023, at 9:15 a.m. Eastern Time.
The Company intends to proceed with the as-adjourned Special Meeting on January 19, 2022 at 11:00 a.m., Pacific Standard Time. However, the Company will not proceed to file the amendment to the Company’s Certificate of Incorporation contemplated by certain matters to be voted on at the Special Meeting pending further order of the Court of Chancery.
The Company’s description of its capital structure in the Proxy Statement assumes that the 2022 Certificate Amendment was validly effectuated. The accuracy of the Company’s description of its capital structure will be confirmed if the Court of Chancery ratifies and validates the 2022 Certificate Amendment.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
MULLEN AUTOMOTIVE INC. Date: January 13, 2023By:/s/ David Michery David Michery Chief Executive Officer
Inline Viewer
Select Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):January 13, 2023
MULLEN AUTOMOTIVE INC.
_____________________________________________________________
(Exact name of registrant as specified in its charter)
Delaware001-3488786-3289406(State or other jurisdiction of
incorporation)(Commission File Number)(IRS Employer Identification No.)
1405 Pioneer Street, Brea, California 92821
(Address, including zip code, of principal executive offices)
Registrant’s telephone number, including area code(714) 613-1900
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registeredCommon Stock, par value $0.001MULNThe Nasdaq Stock Market, LLC (Nasdaq Capital Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 8.01Other Events
On November 25, 2022, Mullen Automotive Inc. (the “Company”) filed a definitive proxy statement with the Securities and Exchange Commission (the “Commission”) in connection with a Special Meeting of Stockholders (the “Special Meeting”), and on December 16, 2022 and January 13, 2023, the Company filed amendment no.1 and amendment no.2 to the definitive proxy statement with the Commission (together the “Proxy Statement”).
The Proxy Statement discloses that, as of the close of business on November 21, 2022 (the “Special Meeting Record Date”), there were 1,659,097,754 shares of Common Stock outstanding, 1,925 shares of Series A Preferred Stock outstanding, one share of Series AA Preferred Stock outstanding, zero shares of Series B Preferred Stock outstanding, and 1,211,757 shares of Series C Preferred Stock outstanding. The Company’s Series D Preferred Stock par value $0.001 per share (the “Series D Preferred Stock”) have no voting rights except in a liquidation event, issuance of equity security having a preference over the Series D Preferred Stock, amendment of the Company’s Certificate of Incorporation or bylaws that adversely affect the rights of the Series D Preferred Stock, corporate dissolution or bankruptcy, as set forth in Section 8 of the Certificate of Designation for Series D Preferred Stock, and therefore the Series D Preferred Stock was not counted in connection to the Special Meeting.
Of these shares outstanding on the Special Meeting Record Date, 1,159,803,273 shares of Common Stock, and one share of Series AA Preferred Stock (collectively, the “New Shares”) were issued by the Company following the enactment of an amendment to the Company’s Certificate of Incorporation (the “2022 Certificate Amendment”) on July 26, 2022. The 2022 Certificate Amendment was approved at the Company’s July 26, 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The 2022 Certificate Amendment increased the number of shares of Common Stock authorized for issuance from 500,000,000 to a total of 1,750,000,000 shares of Common Stock, and increased the number of shares of Preferred Stock authorized for issuance from 58,000,000 to a total of 500,000,000 shares of Preferred Stock, with a corresponding increase in our total authorized capital stock, which includes Common Stock and Preferred Stock, from 558,000,000 shares to 2,250,000,000 shares. The 2022 Certificate Amendment became effective when it was filed with the Office of the Secretary of State of the State of Delaware on July 26, 2022.
On December 7, 2022, a putative stockholder class action was filed in the Court of Chancery of the State of Delaware, styled as Robbins v. Michery, et al., C.A. No. 2022-1131-LWW (the “Robbins Action”). On December 13, 2022, a second putative stockholder class action was filed in the Court of Chancery of the State of Delaware, styled as Foley v. Michery, et al., C.A. No. 2022-1147-LWW (the “Foley Action” and, together with the Robbins Action, the “Stockholder Actions”). The plaintiffs in the Stockholder Actions filed complaints alleging, among other things, that the number of shares of Common Stock issued and outstanding as of the Annual Meeting Record Date (the “Annual Meeting Record Date”) was 477,510,822 and that, based on this eligible share total, a majority of shares of Common Stock, when considered separately as a class, did not vote in favor of the increase in authorized shares at the 2022 Annual Meeting.
The Company does not believe that the filing and effectiveness of the 2022 Certificate Amendment is either invalid or ineffective. However, to resolve any uncertainty, the Company is pursuing actions to ratify the 2022 Certificate Amendment through the filing of a validation proceeding with the Delaware Court of Chancery (the “Court of Chancery”) pursuant to Section 205 of the Delaware General Corporation Law (“Section 205”). Section 205 permits the Court of Chancery, in its discretion, to ratify and validate potentially defective acts. The Court of Chancery has scheduled a hearing to consider the Company’s Section 205 petition on January 23, 2023, at 9:15 a.m. Eastern Time.
The Company intends to proceed with the as-adjourned Special Meeting on January 19, 2022 at 11:00 a.m., Pacific Standard Time. However, the Company will not proceed to file the amendment to the Company’s Certificate of Incorporation contemplated by certain matters to be voted on at the Special Meeting pending further order of the Court of Chancery.
The Company’s description of its capital structure in the Proxy Statement assumes that the 2022 Certificate Amendment was validly effectuated. The accuracy of the Company’s description of its capital structure will be confirmed if the Court of Chancery ratifies and validates the 2022 Certificate Amendment.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
MULLEN AUTOMOTIVE INC. Date: January 13, 2023By:/s/ David Michery David Michery Chief Executive Officer
is either invalid or ineffective. However, to resolve any uncertainty, the Company is pursuing actions to ratify the 2022 Certificate Amendment through the filing of a validation proceeding with the Delaware Court of Chancery (the “Court of Chancery”) pursuant to Section 205 of the Delaware General Corporation Law (“Section 205”). Section 205 permits the Court of Chancery, in its discretion, to ratify and validate potentially defective acts. The Court of Chancery has scheduled a hearing to consider the Company’s Section 205 petition on January 23, 2023, at 9:15 a.m. Eastern Time.
The Company intends to proceed with the as-adjourned Special Meeting on January 19, 2022 at 11:00 a.m., Pacific Standard Time
60/40 and yes they normally fill on a slow day
Typo error about 12%still not bad
Up about 21% premarket.
Very out dated DD
...This is the only remaining valad r/s , statement
U can find the remainder of the artical urself
...
Directors (the “Reverse Stock Split”); provided, however, that the Company will not file such amendment before May 1, 2023 to effect the Reverse Stock Split
As heard on Fox Business:
The administration is giving incentives to delivery companies to switch to EVs. Companies could get $40K and $7500 for individuals starting Jan 1, 2023.
?? calling BS, dosent matter where it's made, it's being sold overseas
Totally outdated DD.
Nov.
Nope, never happening, Sept 2023 is a looonggg way from today. ??
Yep, Sept., 2023,
MULN dosent need a R/S to hit the $1.00. Cert requirements
Twitter, waste of time. Get with Reddit or some decent private chat groups.
GLTU.
MULN,
solid .70+ being chewed up. Nice volume.
MULN
nice move with volume, .67 and moving up.
DANG, only two floaters visible in the last couple posts.
If memory serves a sell is also a buy.
But what the Heck.
FYI.
New to The Street TV Announces its Four Corporate Interviews Airing on the Fox Business Network, Tonight, Monday, March 21, 2022, at 10:30 PM PT and Tomorrow Night, Tuesday, March 22, 2022, at 10:30 PM PT
Anybody see the 0700 update issued prior next week's announcements?
Thank you.
Appreciate it.